Goldman wins €15bn of pharmaceuticals

Goldman Sachs is to advise on a second multi-billion pharmaceutical deal in a week after winning the mandate to advise Altana on the €4.5bn ($5.7bn) sale of its pharma business to private equity-owned Nycomed.

Nycomed, which was advised by Morgan Stanley and Credit Suisse, revealed it had agreed a deal to buy Altana Pharma in a statement last night.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump